Abu Dhabi Biobank and Human Life CORD Japan Announce Strategic Partnership to Advance Umbilical Cord–Derived Therapies in the UAE

Abu Dhabi, UAE — May 6 2026 — Abu Dhabi Biobank, a strategic initiative between the Department of Health – Abu Dhabi, the regulator of the healthcare sector in the Emirate and global health leader M42 announced a strategic partnership with Human Life CORD Japan Inc. (HLC), to localize the development and clinical application of umbilical cord–derived stem cell therapies in Abu Dhabi. This step represents a significant milestone in expanding access to stem cell therapies across the UAE and the wider MENA region, further reinforcing the Emirate’s position as a global leader in advanced healthcare, life sciences and precision medicine. 

The collaboration brings together Abu Dhabi Biobank’s large-scale biobanking, advanced capabilities and translational research infrastructure with HLC’s proprietary MSC technology platform and clinical development expertise. The collaboration aims to accelerate regionally relevant, tailor-made regenerative therapies that address priority health challenges across the UAE and the wider MENA region.

Continue reading Abu Dhabi Biobank Partners with Human Life CORD for Stem Cell Innovations →